Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
Clinical trial NCT01088880 · COMPLETED
Trial details
- NCT number
- NCT01088880
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.